Sylvant Injection, Powder, For Solution
Product Images NDC 73090-421

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sylvant (NDC 73090-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Vial Box)

Packaging label for Sylvant 100 mg injection powder for solution, containing siltuximab. The label specifies intravenous infusion use only and includes reconstitution instructions, storage conditions, manufacturer EUSA Pharma (UK) Ltd, and barcode. The label highlights dosage details and safety warnings, with branding and regulatory information.*

FDA Label Image

Principal Display Panel (400 mg Vial Box)

Packaging label for Sylvant 400 mg, an injection powder for solution containing siltuximab. The label indicates it is for intravenous infusion only, supplied as a single-dose vial. The manufacturer is EUSA Pharma (UK) Ltd. The label includes storage instructions, barcode, NDC 73090-421-01, and preparation directions for reconstitution and dilution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.